Trial of Solanezumab in Preclinical Alzheimer’s DiseaseReisa A. Sperling, Paul Aisen, Michael Donohue et al.|New England Journal of Medicine|2023Cited by 382
Association of Factors With Elevated Amyloid Burden in Clinically Normal Older IndividualsReisa A. Sperling, Michael Donohue, Rema Raman et al.|JAMA Neurology|2020Cited by 330
Amyloid‐Related Imaging Abnormalities in the <scp>DIAN‐TU</scp>‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph‐Mathurin, Richard J. Perrin, Jakub Wojtowicz et al.|Annals of Neurology|2022Cited by 42